Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats

Skin Pharmacol Physiol. 2009;22(5):240-7. doi: 10.1159/000235551. Epub 2009 Aug 18.

Abstract

Although many mouse models of atopic dermatitis have been reported, few rat models have been studied. In this study, a rat chronic allergic dermatitis model was developed and evaluated as a pharmacological model of atopic dermatitis. Prominent ear thickening and scratching were induced after the application of 2,4-dinitrochlorobenzene to the right ear of Brown Norway rats 3 times per week for 3 weeks. Histopathologically, infiltration of T cells in the ear was observed on day 7, and eosinophils and mast cells were found in addition to T cells on day 21. The expression of interferon-gamma and interleukin-4 was increased on day 7 when compared with normal rats. However, interferon-gamma expression had disappeared by day 21. Tacrolimus ointment applied after ear tissue thickening fully developed, suppressed chronic dermatitis in a dose-dependent manner. This model has some symptomatic and histopathological similarities to atopic dermatitis and might be useful in pharmacological studies.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Chronic Disease
  • Dermatitis, Atopic / chemically induced*
  • Dermatitis, Atopic / immunology
  • Dermatitis, Atopic / pathology
  • Dinitrochlorobenzene / administration & dosage
  • Dinitrochlorobenzene / toxicity*
  • Disease Models, Animal*
  • Drug Administration Schedule
  • Ear
  • Haptens / administration & dosage
  • Haptens / toxicity
  • Male
  • Rats
  • Rats, Inbred BN
  • Time Factors

Substances

  • Dinitrochlorobenzene
  • Haptens